Literature DB >> 13930994

Acceleration of growth of sarcoma 180 with pyridoxamine and retardation with penicillamine.

M L LITTMAN, T TAGUCHI, Y SHIMIZU.   

Abstract

Entities:  

Keywords:  CHELATING AGENTS; PYRIDOXINE; SARCOMA 180, CROCKER

Mesh：

Substances：

Year:  1963        PMID： 13930994     DOI： 10.3181/00379727-113-28458

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  5 in total

1.  Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.

Authors:  Steven Brem; Stuart A Grossman; Kathryn A Carson; Pamela New; Surasak Phuphanich; Jane B Alavi; Tom Mikkelsen; Joy D Fisher
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

2.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

Authors:  S S Brem; D Zagzag; A M Tsanaclis; S Gately; M P Elkouby; S E Brien
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

3.  EFFECT OF PYRIDOXINE DEFICIENCY ON NUCLEIC ACID METABOLISM IN THE RAT.

Authors:  A C TRAKATELLIS; A E AXELROD
Journal:  Biochem J       Date:  1965-05       Impact factor: 3.857

4.  Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine.

Authors:  D Yoshida; Y Ikeda; S Nakazawa
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

5.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.